# Daiichi Sankyo Co., Ltd. Hiratsuka Plant – FDA Inspection, Nov 2, 2017

Source: https://www.keypedia.com/records/fda_inspections/daiichi-sankyo-co-ltd-hiratsuka-plant/9070c8d4-53c7-4b95-bbd3-84d004ef030b
Source feed: FDA_Inspections

> FDA inspection 1032011 of Daiichi Sankyo Co., Ltd. Hiratsuka Plant, November 02, 2017. Classification: Voluntary Action Indicated (VAI). 3 citations under 21 CFR part 211. Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1032011
- Company Name: Daiichi Sankyo Co., Ltd. Hiratsuka Plant
- Inspection Date: 2017-11-02
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 3

## Related Documents

- FDA Inspection 1105205 - 2019-08-29
- FDA Inspection 971651 - 2016-04-22
- FDA Inspection 888923 - 2014-06-13

## Related Officers

- [Arsen Karapetyan](https://www.keypedia.com/people/arsen-karapetyan/4000d909-277b-4533-992f-4e3627c8ce40)

Company: https://www.keypedia.com/companies/daiichi-sankyo-co-ltd-hiratsuka-plant/d9bb5238-4acc-4fc5-8638-db754e816be8

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c